𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Subiocalization of the chromosome 5 breakpoint of the 3;5 translocation in myelodysplastic syndromes and acute myeloid leukemia

✍ Scribed by Dr. Stephan W. Morris; John T. Foust; Marcus B. Valentine; W. Mark Roberts; David N. Shapiro; A. Thomas Look


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
688 KB
Volume
5
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


A t(3;5)(q25. I ;q34) reciprocal translocation identifies a subset of cases of myelodysplastic syndrome o r acute myeloid leukemia (AML) that are characterized by increased numbers of megakaryocytes and severe trilineage dysplasia. As a first step in characterizing the t(3;5) breakpoints, we asked whether the translocation involves the CSFl RIPDGFRB locus at 5q33-q35.

Pulsed-field gel electrophoretic analysis of a region extending 580 kb 5' to the PDGFRB gene and I20 kb 3' to the CSFl R gene did not reveal aberrant restriction fragments in leukemic cell DNA, confirming that the breakpoint does not occur in the vicinity of thesegenes. T o sublocalize the breakpoint, we performed Southern blot hybridizations using DNAfrom human x hamster somatic cell hybrids containing the normal 3, the normal 5, the derivative 3, or the derivative 5 human chromosome. Using a series of polymorphic D N A probes from the long arm of chromosome 5, which have been linked by genetic recombination, we bracketed the breakpoint t o within a region that spans%' I 3 centimorgans (sex average) and is flanked by the q34-qter markers cKK5. I9 and L I200 (D5S62). This analysis places the chromosome 5 breakpoint of the t(3;5) considerably telomeric to the CSFIRIPDGFRB locus, confirming our studies with pulsed-field electrophoresis. Future efforts to identify the genes affected by the t(3;S) should focus on the 5q segment described in this study. Genes Chrom Cancer 5:385-391 (1992).


πŸ“œ SIMILAR VOLUMES


Combination of 5-azacytidine and thalido
✍ Azra Raza; Murtaza Mehdi; Muhammad Mumtaz; Fahad Ali; Steven Lascher; Naomi Gali πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 224 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The treatment of myelodysplastic syndromes (MDS) remains a challenge to the clinician despite recent advances. Many patients will either not respond or will have only limited and/or brief responses to single‐agent therapy. Eventually, 30% of patients with MDS will progre

Defining the pathogenic role of telomera
✍ Michael Kirwan; Tom Vulliamy; Anna Marrone; Amanda J. Walne; Richard Beswick; Pe πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 217 KB

The primary pathology in many cases of myelodysplasia (MDS) and acute myeloid leukemia (AML) remains unknown. In some cases, two or more affected members have been identified in the same family. To date, mutations in two genes have been directly implicated: the hematopoietic transcription factors RU

Mapping of translocation breakpoints on
✍ David L. Saltman; Julia D. Mellentin; Stephen D. Smith; Dr. Michael L. Cleary πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 532 KB

## Abstract Non‐random translocations involving the short arm of chromosome 19 are frequently observed in acute leukemias. Recent studies have shown that the 19p13 genes __E2A__ and __LYL1__, both of which encode helix‐loop‐helix proteins, lie at two different translocation breakpoints in acute lym

Characterization of the translocation br
✍ Dr. Panos C. Papadopoulos; Amy M. Greenstein; Robert A. Gaffney; Carol A. Westbr πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 686 KB

We have previously described a patient in whom the breakpoint occurred within the first intron of the BCR gene and have cloned the 9q+ and 22q-junctions. We have now determined the nucleotide sequence around the breakpoints on both translocation products from this patient as well as the correspondin